Literature DB >> 8453468

Sensitization of c-fos expression in rat striatum following multiple challenges with D-amphetamine.

A B Norman1, S Y Lu, J M Klug, R B Norgren.   

Abstract

D-Amphetamine transiently stimulates the expression of the immediate-early response gene, c-fos, in rat striatal cell nuclei. D-Amphetamine (2.5 mg/kg i.p.) induced a significantly greater expression of Fos-like immunoreactivity in striatum of rats treated three days previously with D-amphetamine compared to rats treated three days previously with saline. This increase in the expression of Fos-like immunoreactivity in rat striatum was characterized by a significantly greater number of immunoreactive nuclei and a significant increase in the intensity of the immunoreactivity. This sensitization of c-fos expression following a repeated administration of D-amphetamine indicates an increased activation of post-synaptic elements in rat striatum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453468     DOI: 10.1016/0006-8993(93)91308-f

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

Review 1.  Drugs of abuse and immediate-early genes in the forebrain.

Authors:  R E Harlan; M M Garcia
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

2.  Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals.

Authors:  E J Curran; H Akil; S J Watson
Journal:  Neurochem Res       Date:  1996-11       Impact factor: 3.996

Review 3.  Drug-activated cells: From immediate early genes to neuronal ensembles in addiction.

Authors:  Marine Salery; Arthur Godino; Eric J Nestler
Journal:  Adv Pharmacol       Date:  2021-02-19

4.  Repeated methamphetamine administration differentially alters fos expression in caudate-putamen patch and matrix compartments and nucleus accumbens.

Authors:  Jakub P Jedynak; Courtney M Cameron; Terry E Robinson
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.